Brief: Kancera Q2 Operating Loss Narrows To SEK 15.4 Million
Aug 19 (Reuters) - Kancera AB KANC.ST :
* Q2 OPERATING LOSS SEK 15.4 MILLION VERSUS LOSS SEK 18.2
MILLION
YEAR AGO
* Q2 NET SALES SEK 0 MILLION
Source text for Eikon: ID:nMFN72z5d1
Further company coverage: KANC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing